| Prev Close: | 77.19 |
|---|---|
| Open: | 77.39 |
| Bid: | 80.39 |
| Ask: | 80.43 |
| 1y Target Est: | 83.20 |
| Beta: | N/A |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | 77.00 - 80.64 |
|---|---|
| 52wk Range: | 43.99 - 80.64 |
| Volume: | 1,014,849 |
| Avg Vol (3m): | 485,603 |
| Market Cap: | 24.60B |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Warner Chilcott buy may be Actavis' best takeover defenseat Reuters(Fri, May 17)
- DEALTALK: Warner Chilcott buy may be Actavis' best takeover defenseat Reuters(Fri, May 17)
- Drugmaker Actavis' shares upAP(Thu, May 16)
- Novartis says has no intention of buying Actavisat Reuters(Thu, May 16)
- Ahead of the Bell: Drugmaker Actavis' shares upAP(Thu, May 16)
- What WSJ Canada Is Reading Thursdayat The Wall Street Journal(Thu, May 16)
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsCNW Group(Wed, May 15)
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsPR Newswire(Wed, May 15)
- [$$] Drug Firms Stalk Actavisat The Wall Street Journal(Wed, May 15)
- Actavis rejected $15 billion offer from Mylan: sourceReuters(Tue, May 14)
- Actavis rejected $15 billion offer from Mylan - sourceat Reuters(Tue, May 14)
- Actavis Said to Have Spurned $15 Billion Offer From Mylanat Bloomberg(Tue, May 14)
- Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of ShareholdersCNW Group(Mon, May 13)
- Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of ShareholdersPR Newswire(Mon, May 13)
- Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance ProposalCNW Group(Fri, May 10)
Press Releases
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsCNW Group(Wed, May 15)
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsPR Newswire(Wed, May 15)
- Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of ShareholdersCNW Group(Mon, May 13)
Reports
- Valeant Pharmaceuticals International Inc: Business description, financial summary,...Reuters Investment Profile(May 18)
- Jefferson Research Financial Sonar Report. A detailed analysis of the current...Jefferson Research(May 17)
- ValuEngine - Toronto Quantitative Stock Report for VRXValuEngine, Inc.(May 16)